Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$886M |
| 2 |
Chevron
CVX
|
+$595M |
| 3 |
Union Pacific
UNP
|
+$360M |
| 4 |
Baxter International
BAX
|
+$276M |
| 5 |
Xcel Energy
XEL
|
+$252M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$520M |
| 2 |
NXP Semiconductors
NXPI
|
+$248M |
| 3 |
Oracle
ORCL
|
+$242M |
| 4 |
Amgen
AMGN
|
+$197M |
| 5 |
Eli Lilly
LLY
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 54.77% |
| 2 | Financials | 8.19% |
| 3 | Technology | 7.88% |
| 4 | Healthcare | 6.85% |
| 5 | Industrials | 5.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4851
Genasys
GNSS
$66M
| $528K | ﹤0.01% |
190,494
-7,428
| -4% | -$23.2K |
|
4852
Onto Innovation
ONTO
$16.6B
| $528K | ﹤0.01% |
8,236
-21,089
| -72% | -$1.55M |
|
|
PAQCU
4853
DELISTED
Provident Acquisition Corp. Units
PAQCU
| $528K | ﹤0.01% |
52,206
| – | – |
|
4854
Graham Corp
GHM
$1.01B
| $527K | ﹤0.01% |
59,941
-3,330
| -5% | -$27.8K |
|
4855
Harvard Bioscience
HBIO
$36.1M
| $527K | ﹤0.01% |
20,571
-18,526
| -47% | -$613K |
|
|
IMDX
4856
Insight Molecular Diagnostics
IMDX
$135M
| $527K | ﹤0.01% |
36,069
-13,739
| -28% | -$238K |
|
4857
World Acceptance Corp
WRLD
$878M
| $527K | ﹤0.01% |
5,445
-15,387
| -74% | -$1.78M |
|
|
SOL
4858
DELISTED
Emeren Group
SOL
| $526K | ﹤0.01% |
+104,356
| New | +$595K |
|
4859
PUT
Alaska Air
ALK
$4.72B
| $525K | ﹤0.01% |
+13,400
| New | +$588K |
|
4860
CALL
TransDigm Group
TDG
$65.6B
| $525K | ﹤0.01% |
1,000
-200
| -17% | -$119K |
|
|
WNS
4861
DELISTED
WNS Holdings
WNS
| $524K | ﹤0.01% |
6,402
-252,358
| -98% | -$21M |
|
4862
Bristow Group
VTOL
$1.3B
| $523K | ﹤0.01% |
+22,265
| New | +$581K |
|
4863
XBP Global Holdings
XBP
$34.9M
| $523K | ﹤0.01% |
5,125
-793
| -13% | -$80.7K |
|
4864
Inogen
INGN
$146M
| $522K | ﹤0.01% |
+21,490
| New | +$593K |
|
|
ONCT
4865
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $522K | ﹤0.01% |
29,245
-35,561
| -55% | -$763K |
|
|
SCRMU
4866
DELISTED
Screaming Eagle Acquisition Corp. Unit
SCRMU
| $521K | ﹤0.01% |
53,371
-2,850,289
| -98% | -$27.8M |
|
|
BFX
4867
DELISTED
BowFlex Inc.
BFX
| $520K | ﹤0.01% |
318,714
-57,143
| -15% | -$115K |
|
|
ITQRU
4868
DELISTED
Itiquira Acquisition Corp. Unit
ITQRU
| $520K | ﹤0.01% |
52,395
-571
| -1% | -$5.65K |
|
4869
PUT
Eastman Chemical
EMN
$8.35B
| $519K | ﹤0.01% |
+7,300
| New | +$656K |
|
|
FOLD
4870
DELISTED
Amicus Therapeutics
FOLD
| $519K | ﹤0.01% |
49,704
-215,509
| -81% | -$2.4M |
|
4871
CALL
Puma Biotechnology
PBYI
$468M
| $518K | ﹤0.01% |
+218,600
| New | +$638K |
|
|
RJET
4872
Republic Airways Holdings
RJET
$861M
| $517K | ﹤0.01% |
20,887
-13,377
| -39% | -$459K |
|
|
SHYF
4873
DELISTED
The Shyft Group
SHYF
| $517K | ﹤0.01% |
25,295
+10,646
| +73% | +$248K |
|
|
AGEN
4874
Agenus
AGEN
$345M
| $516K | ﹤0.01% |
12,821
-117,737
| -90% | -$6M |
|
|
CARM
4875
DELISTED
Carisma Therapeutics
CARM
| $516K | ﹤0.01% |
60,740
-73,202
| -55% | -$997K |
|
Similar funds
Israel Englander's Q3 2022 Portfolio in Review
As of Q3 2022, Israel Englander held 7,917 positions worth $169B, up 4.9% from $161B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Israel Englander deployed $7.73B of net new capital in Q3 2022, opening 1,005 new positions and adding to 2,598 existing holdings. Its largest new stake was Rockwell Automation: 953,525 shares worth $205M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 55% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $520M trimmed.
- Israel Englander's largest Q3 2022 buy was Rockwell Automation: 953,525 shares worth $205M.
- Israel Englander added most to Duke Realty Corp. in Q3 2022, an estimated $886M increase.
- Israel Englander's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $520M.
- Israel Englander fully exited Coherent Inc in Q3 2022, selling an estimated $114M.
- Israel Englander's ten largest holdings make up 23% of its $169B portfolio in Q3 2022.
- Israel Englander opened 1,005 new positions and closed 906 in Q3 2022.
- Israel Englander's portfolio value rose 4.9% quarter-over-quarter to $169B.
Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.